Epilepsy Flashcards
Define epilepsy
Recurrent unprovoked seizures resulting from excessive neuronal discharge
Define SUDEP
Sudden unexpected witnessed or unwitnessed, non traumatic and non drowning death in a patient with epilepsy with or without evidence of a seizure and excluding documented status epilepticus in which postmortem doesn’t reveal a toxicology or anatomic cause of death.
What is the prevalence of epilepsy in.child bearing age?
0.5-1%
WHAT is the most common cause of SUDEP?
Generalized tonic colonic seizures
Or Grand mal seizures
How much is the risk of death increases in pregnant women with epilepsy
10 folds
Who we consider as low risk women in pregnancy
10 years no seizure attack or 5 years is well controlled without AEDS
What are the important features of preconception counselling for WWE
- Compliance with AED
- Drug adjustment
- Folic acid 5 mg/day
What is the risk of congenital anomaly in WWE not taking AED
2 - 2.3%
What are the factors contributing to deterioration of epilepsy in pregnancy
- Poorly contolled epilepsy prior to pregnancy
- Seizure frequency of more than
1 per month - Multiple seizure type
- Drug resistant epilepsy
- High dose polytherapy
- Poor compliance
- Reduce drug concentrations due to increase clearance and pregnancy.
- Specific Nausea, vomiting, sleep deprivation, labour pain and hyperventilation
What are the risk of epileptic fits on fetus?
- Increase risk of IUGR
- Increase risk of hypoxia
- Developing childhood epilepsy
What are the medication you will prescribe pre conceptual and in early pregnancy for WWE
- Folic acid supplementation
- taking AED at lowest dose, usually monotherapy, avoid sodium valproate
What are thesuggested AED in pregnancy
Levoteracetam
Lamotrigine
Carbamazepine
Sodium valproate is associated with which congenital anomalies
Facial cleft
NTD
poor cognition & neurodevelopment
hypospadias
Phenobarbital and phenytoin are associated with?
Cardiac defects
Fascial cleft
Risk of malformation with sodium valproate
6-10%
Risk of malformation with lamotrigine 300 mg
2-5%